Nihon Kakaku Pharmaceutical completed the disposal of 43,463 shares of treasury stock issued as share-restricted stock compensation, raising a total of 89.38 million yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4272","jir_company_name":"Nihon Kakaku Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-07-17","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4272-20260717-01.pdf","jir_short_summary":"Nihon Kakaku Pharmaceutical completed the disposal of 43,463 shares of treasury stock issued as share-restricted stock compensation, raising a total of 89.38 million yen.","jir_summary":"### Overview of Disposal\nNihon Kakaku Pharmaceutical completed the procedure for the disposal of 43,463 shares of treasury stock issued as share-restricted stock compensation on July 17, 2026. The disposal price was 2,056.5 yen per share, totaling 89.38 million yen. The disposal was conducted for five directors and twelve executive officers, but details regarding the purpose of fundraising and future shareholder return policies have not been disclosed.\n\n### Impact on Shareholders and Future Outlook\nThis share disposal was carried out as part of the company's share compensation scheme to prevent dilution of shareholder value and to enhance executive incentives. The company intends to continue appropriate share management and shareholder return policies as part of its capital policy.","jir_financial_highlights":"Number of shares disposed: 43,463 shares (unknown)\nDisposal amount: 89,381,662 yen (unknown)\nDisposal amount (per share): 2,056.5 yen (unknown)","jir_category":"","jir_hashtags":"#NihonKakakuPharmaceutical, #ShareBuyback, #IR, #JapaneseStocks","jir_key_figures":"Number of shares disposed: 43,463 shares\nDisposal amount: 89,381,662 yen\nDisposal amount (per share): 2,056.5 yen","jir_meta_title":"\u3010Nihon Kakaku Pharmaceutical\u3011Share Buyback Completed | July 2026","jir_meta_description":"Nihon Kakaku Pharmaceutical completed the disposal of 43,463 shares of treasury stock on July 17, 2026, raising a total of 89.38 million yen. As part of its capital policy.","jir_og_title":"\u3010Nihon Kakaku Pharmaceutical\u3011Share Buyback Completed | July 2026","jir_og_description":"Nihon Kakaku Pharmaceutical has completed the share disposal and has proceeded with fundraising as part of its capital policy. Please see the IR materials for details.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8762,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_cancellation","footnotes":""},"sector":[],"importance":[],"class_list":["post-82657","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n